MAPT and Alzheimer disease: Collectively, these results highlight that p300 is elevated in MTG neurons of patients with AD and illustrate that increased expression of the AAV-Rbbp7 reduces p300 levels, which help to explain the observed reductions in tau acetylation and phosphorylation.